There are 2 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - Senate

Short Titles as Reported to Senate

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

Short Titles as Introduced

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend and reauthorize the controlled substance monitoring program under section 399O of the Public Health Service Act.


Actions Overview (2)

Date
04/27/2016 Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
02/12/2015 Introduced in Senate

All Actions (4)

Date
04/27/2016 Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.
Action By: Senate
04/27/2016 Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Action By: Senate Health, Education, Labor, and Pensions
03/16/2016 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Action By: Senate Health, Education, Labor, and Pensions
02/12/2015 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Action By: Senate

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Health, Education, Labor, and Pensions02/12/2015 Referred to
03/16/2016 Markup by
04/27/2016 Reported by

Related Bills (2)

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (12)

  • Congressional oversight
  • Criminal justice information and records
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Health information and medical records
  • Health programs administration and funding
  • Health technology, devices, supplies
  • Licensing and registrations
  • Medical research
  • Prescription drugs
  • State and local government operations

Latest Summary (2)

There are 2 summaries for S.480. View summaries

Shown Here:
Reported to Senate with amendment(s) (04/27/2016)

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

(Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain existing state controlled substance monitoring programs;
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
  • require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request;
  • require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and
  • expand the program to include any commonwealth or territory of the United States.

The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.